Alerts will be sent to your verified email
Verify EmailVINEETLAB
Vineet Laboratories
|
Concord Drugs
|
Unick Fix-A-Form
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
6.26 % | 3.38 % | 9.15 % |
5yr average Equity Multiplier
|
3.18 | 1.86 | 2.49 |
5yr Average Asset Turnover Ratio
|
1.36 | 0.9 | 0.88 |
5yr Avg Net Profit Margin
|
1.11 % | 1.88 % | 4.16 % |
Price to Book
|
1.24 | 0.91 | 1.05 |
P/E
|
0.0 | 0.0 | 12.88 |
5yr Avg Cash Conversion Cycle
|
89.15 Days | 260.53 Days | 21.15 Days |
Inventory Days
|
66.38 Days | 138.17 Days | 48.34 Days |
Days Receivable
|
80.91 Days | 144.77 Days | 79.56 Days |
Days Payable
|
81.06 Days | 77.93 Days | 119.31 Days |
5yr Average Interest Coverage Ratio
|
2.14 | 1.8 | 2.62 |
5yr Avg ROCE
|
14.46 % | 8.9 % | 12.8 % |
5yr Avg Operating Profit Margin
|
3.72 % | 9.09 % | 14.14 % |
5 yr average Debt to Equity
|
0.69 | 0.55 | 0.86 |
5yr CAGR Net Profit
|
n/a | -21.63 % | -7.47 % |
5yr Average Return on Assets
|
1.2 % | 1.77 % | 3.64 % |
Shareholdings
|
|||
Promoter Holding
|
35.85 % | 54.39 % | 71.57 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-0.11 % | 5.39 % | 35.92 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Vineet Laboratories
|
Concord Drugs
|
Unick Fix-A-Form
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|